Catalyst Wire Dossier Catalyst Wire Dossier

Iodine-131 anti-B1 antibody

iodine-131 labeled anti-B1 antibody · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for Iodine-131 anti-B1 antibody, covering 2012-01-26 to 2017-07-25. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Iodine-131 Anti-B1 Antibody for Non Hodgkin's Lymphoma (NHL) Patients With Greater Than 25% Bone Marrow Involvement [Phase 1]

See pricing